Cargando…
含地西他滨预处理方案异基因造血干细胞移植治疗骨髓增生异常综合征/慢性粒-单核细胞白血病的疗效及安全性
OBJECTIVE: To assess the efficacy and toxicity of decitabine-based conditioning regimen in patients with myelodysplastic syndrome (MDS), acute myeloid leukemia secondary to MDS (MDS-AML) or chronic myelomonocytic leukemia (CMML). METHODS: From March 1, 2013 to May 25, 2015, 22 patients who underwent...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342392/ https://www.ncbi.nlm.nih.gov/pubmed/31340618 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.06.004 |
Ejemplares similares
-
含10天地西他滨预处理方案异基因造血干细胞移植治疗31例急性髓系白血病/骨髓增生异常综合征患者的疗效及安全性
Publicado: (2023) -
地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变
Publicado: (2018) -
地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析
Publicado: (2015) -
地西他滨单药与CAG/HAG方案治疗难治性贫血伴有原始细胞增多的疗效和安全性比较
Publicado: (2017) -
地西他滨对急性T淋巴细胞白血病细胞株Molt4细胞的作用及其机制研究
Publicado: (2015)